Bob Dagher
Chief Tech/Sci/R&D Officer at BRAINSTORM CELL THERAPEUTICS INC.
Net worth: 134 596 $ as of 2024-04-29
Profile
Dr. Bob Dagher, MD, is a Chief Medical Officer & Executive Vice President at Brainstorm Cell Therapeutics, Inc. Dr. Dagher was previously employed as a Chief Medical Officer by Enveric Biosciences, Inc., a Chief Medical Officer-WCG MedAvante-ProPhase by Cadent Therapeutics, Inc., a Senior Medical Director by Covance, Inc., and a Chief Medical Officer by MedAvante-ProPhase, Inc. He received his undergraduate degree from Université de Bordeaux and an undergraduate degree from Faculté De Médecine Necker Enfants Malades Université.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-16 | 253,000 ( 0.37% ) | 134 596 $ | 2024-04-29 |
Bob Dagher active positions
| Companies | Position | Start |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2024-04-15 |
Former positions of Bob Dagher
| Companies | Position | End |
|---|---|---|
| ENVERIC BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2022-12-31 |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2021-11-30 |
| COVANCE INC. | Chief Tech/Sci/R&D Officer | 2018-12-31 |
| MedAvante-ProPhase, Inc. | Chief Tech/Sci/R&D Officer | - |
Training of Bob Dagher
| Faculté De Médecine Necker Enfants Malades Université | Undergraduate Degree |
| Université de Bordeaux | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ENVERIC BIOSCIENCES, INC. | Health Technology |
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| Private companies | 3 |
|---|---|
| MedAvante-ProPhase, Inc. | |
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Bob Dagher